Conspectus Electrochemical organic oxidation reactions are highly appealing because
protons are often effective terminal electron acceptors, thereby avoiding undesirable …

Inflammation participates critically in atherosclerosis. Circulating levels of several
inflammatory markers rise in individuals at risk for atherosclerotic events. In particular …

Although LDL cholesterol (LDL‐C) is associated with an increased risk of coronary heart
disease, other lipoproteins and their constituents, apolipoproteins, may play an important …

Abstract Statins, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, are currently
the most effective lipid-lowering drugs, effectively reducing the plasma total cholesterol and …

Much preclinical and epidemiological evidence supports the anticancer effects of statins.
Epidemiological evidence does not suggest an association between statin use and reduced …

Low-density lipoprotein (LDL) cholesterol is an established risk factor for coronary heart
disease (CHD). In the presence of oxidative stress LDL particles can become oxidized to …

Electrocatalytic methods for organic synthesis could offer sustainable alternatives to
traditional redox reactions, but strategies are needed to enhance the performance of …

Background: Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitor,
or statin, that has been developed for the treatment of dyslipidemia. Objective: This study …

Statins are an efficacious and well-tolerated class of lipid-altering agents that have been
shown to reduce the risk of initial and recurrent cardiovascular events. However, cerivastatin …

Background Coadministration of statins and gemfibrozil is associated with an increased risk
for myopathy, which may be due in part to a pharmacokinetic interaction. Therefore the effect …